SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-058990
Filing Date
2021-04-30
Accepted
2021-04-30 16:05:40
Documents
5
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2114484-1_def14a.htm DEF 14A 792553
2 GRAPHIC lg_eyegatepharma-4c.jpg GRAPHIC 48517
3 GRAPHIC sg_stephenfrom-bw.jpg GRAPHIC 11170
4 GRAPHIC tm2114484d1-pc_pg01proxybw.jpg GRAPHIC 1014187
5 GRAPHIC tm2114484d1-pc_pg02proxybw.jpg GRAPHIC 643593
  Complete submission text file 0001104659-21-058990.txt   3154881
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36672 | Film No.: 21877829
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences